Xiao Lei Gu

BBI Life Sciences Corp. is an investment holding company that engages in the development, manufacture, and sale of various life sciences products used in scientific research. The firm also provides life sciences related services. It operates through the following segments: DNA Synthesis Products, Genetic Engineering Services, Life Sciences Research Consumables, and Protein and Antibody Related Products and Services. The DNA Synthesis Products segment comprises of oligonucleotide synthesis and gene synthesis. The Genetic Engineering Services segment includes DNA sequencing, next generation sequencing, and molecular biology services. The Life Sciences Research Consumables segment refers to experimental materials, such as biochemical reagents, and research kits and consumable parts for experiments. The Protein and Antibody Related Products and Services segment involves protein and antibody related products used for immunology experiments. The company was founded on July 10, 2013 and is headquartered in Shanghai, China.